• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞在化脓性汗腺炎发病机制中的关键作用。

The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.

机构信息

Faculty of Medicine, University of Toronto, Toronto, Canada.

Division of Dermatology, University of Toronto, Toronto, Canada.

出版信息

Inflamm Res. 2017 Nov;66(11):931-945. doi: 10.1007/s00011-017-1074-y. Epub 2017 Jun 27.

DOI:10.1007/s00011-017-1074-y
PMID:28656364
Abstract

INTRODUCTION

Hidradenitis suppurativa (HS) is a painful chronic inflammatory disease with a prevalence between 1 and 4% of general population. The pathogenesis of HS long eluded scientists, but growing evidence suggests that it is a consequence of inflammatory dysregulation.

FINDINGS

Recent studies suggest that dysregulated immune response to skin flora and overexpression of inflammatory cytokines leads to chronic skin inflammation seen in HS. Macrophages are the most numerous inflammatory cells found in HS infiltrates and release numerous pro-inflammatory cytokines such as IL-23, and IL-1β and TNF-α, exacerbating the inflammation and contributing to the pathogenesis of HS. Furthermore, in HS, there is dysregulated function of other immune players closely associated with macrophage function including: matrix metalloproteases (MMP) 2 and 9 overexpression, toll-like receptor upregulation, impaired Notch signalling, NLRP3 inflammasome upregulation, and dysregulated keratinocyte function. Lifestyle factors including obesity and smoking also contribute to macrophage dysfunction and correlate with HS incidence.

CONCLUSIONS

The overexpression of pro-inflammatory cytokines and subsequent efficacy of anti-cytokine biologic therapies highlights the importance of managing macrophage dysfunction. Future therapies should target key molecular drivers of macrophage dysfunction such as TLR2 and NLRP3 overexpression.

摘要

简介

化脓性汗腺炎(HS)是一种疼痛的慢性炎症性疾病,其普通人群的患病率在 1%至 4%之间。HS 的发病机制长期以来一直困扰着科学家,但越来越多的证据表明,它是炎症失调的结果。

发现

最近的研究表明,对皮肤菌群的免疫反应失调和炎症细胞因子的过度表达导致 HS 中所见的慢性皮肤炎症。巨噬细胞是 HS 浸润中数量最多的炎症细胞,释放许多促炎细胞因子,如 IL-23、IL-1β 和 TNF-α,从而加重炎症并促进 HS 的发病机制。此外,在 HS 中,与巨噬细胞功能密切相关的其他免疫细胞的功能也失调,包括:基质金属蛋白酶(MMP)2 和 9 的过度表达、 Toll 样受体上调、Notch 信号受损、NLRP3 炎性体上调以及角质形成细胞功能失调。生活方式因素,包括肥胖和吸烟,也会导致巨噬细胞功能障碍,并与 HS 的发病率相关。

结论

促炎细胞因子的过度表达以及随后的抗细胞因子生物疗法的疗效突出了管理巨噬细胞功能障碍的重要性。未来的治疗方法应针对 TLR2 和 NLRP3 过度表达等巨噬细胞功能障碍的关键分子驱动因素。

相似文献

1
The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.巨噬细胞在化脓性汗腺炎发病机制中的关键作用。
Inflamm Res. 2017 Nov;66(11):931-945. doi: 10.1007/s00011-017-1074-y. Epub 2017 Jun 27.
2
Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.在化脓性汗腺炎的皮损和非皮损皮肤中,细胞因子表达失调。
Br J Dermatol. 2015 Dec;173(6):1431-9. doi: 10.1111/bjd.14075. Epub 2015 Nov 17.
3
Inflammatory Mechanisms in Hidradenitis Suppurativa.化脓性汗腺炎的炎症机制
Dermatol Clin. 2016 Jan;34(1):51-8. doi: 10.1016/j.det.2015.08.004.
4
Hidradenitis Suppurativa as a Potential Subtype of Autoinflammatory Keratinization Disease.化脓性汗腺炎可能是一种炎症性角化病的潜在亚型。
Front Immunol. 2020 May 20;11:847. doi: 10.3389/fimmu.2020.00847. eCollection 2020.
5
Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.细胞因子途径与研究性靶向治疗在化脓性汗腺炎中的应用
Int J Mol Sci. 2020 Nov 10;21(22):8436. doi: 10.3390/ijms21228436.
6
Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology.翻译:在化脓性汗腺炎中 Notch-MKP-1 信号受损:通过转化生物学证据探讨发病机制。
Exp Dermatol. 2013 Mar;22(3):172-7. doi: 10.1111/exd.12098.
7
IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.白细胞介素-17 在炎症性皮肤病银屑病和化脓性汗腺炎中的作用。
Clin Exp Immunol. 2020 Aug;201(2):121-134. doi: 10.1111/cei.13449. Epub 2020 Jun 8.
8
Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.化脓性汗腺炎:将炎症途径整合到一个连贯的致病模型中的系统评价。
Front Immunol. 2018 Dec 14;9:2965. doi: 10.3389/fimmu.2018.02965. eCollection 2018.
9
Inherent differences in keratinocyte function in hidradenitis suppurativa: Evidence for the role of IL-22 in disease pathogenesis.化脓性汗腺炎中角质形成细胞功能的内在差异:白细胞介素-22在疾病发病机制中作用的证据。
Immunol Invest. 2018 Jan;47(1):57-70. doi: 10.1080/08820139.2017.1377227. Epub 2017 Oct 3.
10
Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa.角朊细胞和中性粒细胞是化脓性汗腺炎中促炎分子的重要来源。
Br J Dermatol. 2016 Mar;174(3):514-21. doi: 10.1111/bjd.14214. Epub 2015 Dec 12.

引用本文的文献

1
The Role of Cutaneous B-Cells in Hidradenitis Suppurativa: From Preclinical Evidence to Novel Targeted Therapies.皮肤B细胞在化脓性汗腺炎中的作用:从临床前证据到新型靶向治疗
Exp Dermatol. 2025 Sep;34(9):e70163. doi: 10.1111/exd.70163.
2
Current Treatments and Future Directions for Hidradenitis Suppurativa: a Narrative Review of Completed and Ongoing Phase 3 Clinical Trials of Biologic Therapies.化脓性汗腺炎的当前治疗方法与未来方向:生物疗法已完成及正在进行的3期临床试验的叙述性综述
Dermatol Ther (Heidelb). 2025 Jul 18. doi: 10.1007/s13555-025-01487-y.
3
The Sebaceous Gland: A Key Player in the Balance Between Homeostasis and Inflammatory Skin Diseases.

本文引用的文献

1
Hidradenitis suppurativa treated with tetracycline in combination with colchicine: a prospective series of 20 patients.四环素联合秋水仙碱治疗化脓性汗腺炎:20例患者的前瞻性研究系列
Int J Dermatol. 2017 Mar;56(3):346-350. doi: 10.1111/ijd.13428. Epub 2017 Jan 4.
2
Interferon-gamma (IFN-γ) is Elevated in Wound Exudate from Hidradenitis Suppurativa.γ干扰素(IFN-γ)在化脓性汗腺炎伤口渗出液中升高。
Immunol Invest. 2017 Feb;46(2):149-158. doi: 10.1080/08820139.2016.1230867. Epub 2016 Nov 7.
3
Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease Successfully Treated with Anakinra.
皮脂腺:维持体内平衡与炎症性皮肤病平衡的关键因素。
Cells. 2025 May 20;14(10):747. doi: 10.3390/cells14100747.
4
Plant-Based Foods for Chronic Skin Diseases: A Focus on the Mediterranean Diet.用于慢性皮肤病的植物性食物:聚焦地中海饮食。
Curr Nutr Rep. 2025 Mar 6;14(1):42. doi: 10.1007/s13668-025-00632-5.
5
CD2 expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in hidradenitis suppurativa.表达 CD2 的固有淋巴细胞和 T 细胞是化脓性汗腺炎发病机制中的关键效应细胞。
Proc Natl Acad Sci U S A. 2024 Nov 26;121(48):e2409274121. doi: 10.1073/pnas.2409274121. Epub 2024 Nov 19.
6
Adalimumab Treatment Effects on Inflammation and Adipose Tissue Mitochondrial Respiration in Hidradenitis Suppurativa.阿达木单抗治疗对化脓性汗腺炎炎症和脂肪组织线粒体呼吸的影响。
Endocrinol Diabetes Metab. 2024 Nov;7(6):e70002. doi: 10.1002/edm2.70002.
7
Metformin: A Potential Treatment for Acne, Hidradenitis Suppurativa and Rosacea.二甲双胍:痤疮、化脓性汗腺炎和酒渣鼻的潜在治疗方法。
Acta Derm Venereol. 2023 Dec 11;103:adv18392. doi: 10.2340/actadv.v103.18392.
8
Hidradenitis suppurativa - biologic therapy and other available treatment options.化脓性汗腺炎——生物治疗及其他可用的治疗选择。
Postepy Dermatol Alergol. 2023 Aug;40(4):518-528. doi: 10.5114/ada.2021.112075. Epub 2022 Jan 18.
9
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa.深入了解化脓性汗腺炎的分子发病机制和免疫调节治疗。
Int J Mol Sci. 2023 May 8;24(9):8428. doi: 10.3390/ijms24098428.
10
Bone Metabolism in Patients with Hidradenitis Suppurativa: A Case-control Study.化脓性汗腺炎患者的骨代谢:一项病例对照研究。
Acta Derm Venereol. 2022 Nov 29;102:adv00825. doi: 10.2340/actadv.v102.3504.
托珠单抗成功治疗与成人斯蒂尔病相关的巨噬细胞活化综合征。
Case Rep Rheumatol. 2016;2016:3717392. doi: 10.1155/2016/3717392. Epub 2016 Oct 12.
4
Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up.口服克林霉素和利福平联合治疗化脓性汗腺炎:一项前瞻性研究及1年随访
Clin Exp Dermatol. 2016 Dec;41(8):852-857. doi: 10.1111/ced.12933. Epub 2016 Oct 18.
5
Low-dose systemic corticosteroid treatment for recalcitrant hidradenitis suppurativa.低剂量全身性皮质类固醇治疗顽固性化脓性汗腺炎。
J Am Acad Dermatol. 2016 Nov;75(5):1059-1062. doi: 10.1016/j.jaad.2016.06.001.
6
Patients with hidradenitis suppurativa have no increased risk of Alzheimer disease.化脓性汗腺炎患者患阿尔茨海默病的风险并未增加。
Br J Dermatol. 2017 Jul;177(1):273-275. doi: 10.1111/bjd.15064. Epub 2017 May 23.
7
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.阿达木单抗治疗化脓性汗腺炎的两项 3 期临床试验。
N Engl J Med. 2016 Aug 4;375(5):422-34. doi: 10.1056/NEJMoa1504370.
8
Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?化脓性汗腺炎/反向痤疮:一种内分泌皮肤疾病?
Rev Endocr Metab Disord. 2016 Sep;17(3):335-341. doi: 10.1007/s11154-016-9366-z.
9
Intrinsic Defect in Keratinocyte Function Leads to Inflammation in Hidradenitis Suppurativa.角质形成细胞功能的内在缺陷导致化脓性汗腺炎中的炎症。
J Invest Dermatol. 2016 Sep;136(9):1768-1780. doi: 10.1016/j.jid.2016.04.036. Epub 2016 May 17.
10
An Update on Medical Treatment Options for Hidradenitis Suppurativa.关于化脓性汗腺炎的治疗选择的最新进展。
Drugs. 2016 Feb;76(2):215-29. doi: 10.1007/s40265-015-0516-5.